ArticleCureus2025

Clinical Profile and Outcome of Patients With Advanced Hepatocellular Carcinoma (HCC) Taking Sorafenib or Lenvatinib: Real-World Experience From a Low-Middle Resource Country.

Kinza Sabir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.